To view a copy of this license, visit About this article Cite this article Yoo, H.C., Yu, Y.C., Sung, Y
1995 Mar;23(3):436-49
Market Segmentation Drug Type Insights (Revenue, USD Bn, 2021 - 2033) Semaglutide Liraglutide Exenatide Dulaglutide Tirzepatide Others Linagliptin Lixisenatide Brand Insights (Revenue, USD Bn, 2021 - 2033) Saxenda Victoza Ozempic Wegovy Rybelsus Trulicity Pen Zepbound Mounjaro BYDUREON BCise Others Application Insights (Revenue, USD Bn, 2021 - 2033) Type 2 Diabetes Mellitus Weight Management (Obesity/Overweight) Cardiovascular Risk Reduction Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) Oral Parenteral Type Insights (Revenue, USD Bn, 2021 - 2033) Brand Generic Gender Insights (Revenue, USD Bn, 2021 - 2033) Male Female Age Group Insights (Revenue, USD Bn, 2021 - 2033) Adult Pediatric/Children Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S
J.VarshavskyA